Literature DB >> 10608858

Subcellular compartmentalization of activation and desensitization of responses mediated by NK2 neurokinin receptors.

J Y Vollmer1, P Alix, A Chollet, K Takeda, J L Galzi.   

Abstract

A functional fluorescent neurokinin NK2 receptor was constructed by joining enhanced green fluorescent protein to the amino-terminal end of the rat NK2 receptor and was expressed in human embryonic kidney cells. On cell suspensions, the binding of fluorescent Bodipy-labeled neurokinin A results in a saturatable and reversible decrease of NK2 receptor fluorescence via fluorescence resonance energy transfer. This can be quantified for nM to microM agonist concentrations and monitored in parallel with intracellular calcium responses. On single cells, receptor site occupancy and local agonist concentration can be determined in real time from the decrease in receptor fluorescence. Simultaneous measurement of intracellular calcium responses and agonist binding reveals that partial receptor site occupancy is sufficient to desensitize cellular response to a second agonist application to the same membrane area. Subsequent stimulation of a distal membrane area leads to a second response to agonist, provided that it had not been exposed to agonist during the first application. Together with persistent translocation of fluorescent protein kinase C to the membrane area exposed to agonist, the present data support that not only homologous desensitization but also heterologous desensitization of NK2 receptors is compartmentalized to discrete membrane domains.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10608858     DOI: 10.1074/jbc.274.53.37915

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  A Fluorescent Live Imaging Screening Assay Based on Translocation Criteria Identifies Novel Cytoplasmic Proteins Implicated in G Protein-coupled Receptor Signaling Pathways.

Authors:  Sandra Lecat; Hans W D Matthes; Rainer Pepperkok; Jeremy C Simpson; Jean-Luc Galzi
Journal:  Mol Cell Proteomics       Date:  2015-03-10       Impact factor: 5.911

2.  Detection of human immunodeficiency virus type 1 Nef and CD4 physical interaction in living human cells by using bioluminescence resonance energy transfer.

Authors:  David Cluet; Christophe Bertsch; Christian Beyer; Liliane Gloeckler; Mathieu Erhardt; Jean-Pierre Gut; Jean-Luc Galzi; Anne-Marie Aubertin
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  PIP2 signaling in lipid domains: a critical re-evaluation.

Authors:  Jacco van Rheenen; Eskeatnaf Mulugeta Achame; Hans Janssen; Jero Calafat; Kees Jalink
Journal:  EMBO J       Date:  2005-04-21       Impact factor: 11.598

4.  S-nitrosoglutathione inhibits cerebrovascular angiotensin II-dependent and -independent AT1 receptor responses: A possible role of S-nitrosation.

Authors:  Marie-Lynda Bouressam; Sandra Lecat; Alexandre Raoul; Caroline Gaucher; Caroline Perrin-Sarrado; Isabelle Lartaud; François Dupuis
Journal:  Br J Pharmacol       Date:  2019-05-07       Impact factor: 8.739

5.  Molecular characterization of dopamine D2 receptor isoforms tagged with green fluorescent protein.

Authors:  Keyvan Sedaghat; Marie-France Nantel; Simon Ginsberg; Véronique Lalonde; Mario Tiberi
Journal:  Mol Biotechnol       Date:  2006-09       Impact factor: 2.860

Review 6.  Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications.

Authors:  Jean-Luc Galzi; Muriel Hachet-Haas; Dominique Bonnet; Francois Daubeuf; Sandra Lecat; Marcel Hibert; Jacques Haiech; Nelly Frossard
Journal:  Pharmacol Ther       Date:  2010-02-01       Impact factor: 12.310

7.  A strategy to discover decoy chemokine ligands with an anti-inflammatory activity.

Authors:  Dayana Abboud; François Daubeuf; Quoc Tuan Do; Valérie Utard; Pascal Villa; Jacques Haiech; Dominique Bonnet; Marcel Hibert; Philippe Bernard; Jean-Luc Galzi; Nelly Frossard
Journal:  Sci Rep       Date:  2015-10-07       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.